...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Phase 3 BETonMACE Trial is Now Completed. Cognition and CKD Sub-Study Results to be Announced Soon.

Free
Message: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

Good Endpoints article on Biogen.

https://endpts.com/analyst-brian-skorney-goes-grizzly-on-biogens-alzheimers-hype-fearmongering-and-statistical-malpractice/

Also, forgive my perpetuation of confusion. Biogen's Aducanumab and BAN2401 are two separate drugs that both tackle amyloid. I previously implied that they were one and the same.

BearDownAZ

Share
New Message
Please login to post a reply